Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
Health Technology » Biotechnology
|GILD||Gilead Sciences, Inc.||0.09%||69.71||1.0%||$515.13m|
|VRTX||Vertex Pharmaceuticals, Inc.||0.68%||206.61||1.9%||$454.10m|
|REGN||Regeneron Pharmaceuticals, Inc.||2.98%||654.04||2.7%||$419.38m|
|SNSS||Sunesis Pharmaceuticals, Inc.||1.16%||4.36||0.7%||$304.78m|
|EXAS||EXACT Sciences Corp.||3.48%||86.26||18.0%||$150.95m|
|BMRN||BioMarin Pharmaceutical, Inc.||2.62%||88.38||4.2%||$138.75m|
Xenon Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company. It develops therapeutics to improve the lives of patients with neurological disorders, including rare central nervous system (CNS) conditions. The company's products include XEN496, XEN1101, XEN901 and XEN007. Xenon Pharmaceuticals was founded by Simon Neil Pimstone, Johannes J. P. Kastelein and Michael R. Hayden on November 5, 1996 and is headquartered in Burnaby, Canada.